Sale!

Lyme Disease Borrelia Burgdorferi DNA Qualitative Real-Time PCR Test

3,460 د.إ

-10%

The “Lyme Disease Borrelia Burgdorferi DNA Qualitative Real-Time PCR Test” is a sophisticated diagnostic procedure offered by DNA Labs UAE, designed to detect the presence of Borrelia burgdorferi, the bacteria responsible for Lyme disease. Utilizing the highly sensitive and specific method of Real-Time Polymerase Chain Reaction (PCR), this test identifies the DNA of the bacteria, enabling early and accurate diagnosis of the disease. The cost of the test is 3460 AED.

Lyme disease is a tick-borne illness that can lead to serious health issues if left untreated, including neurological problems and chronic joint inflammation. Early detection through the Borrelia Burgdorferi DNA test can significantly improve treatment outcomes by allowing for prompt and appropriate medical intervention. This test is particularly useful for individuals who have been bitten by a tick or have symptoms suggestive of Lyme disease and have been in areas where the disease is known to be endemic.

DNA Labs UAE, by offering this test, provides a crucial service for the effective management and control of Lyme disease, helping to mitigate the potential long-term health impacts associated with this condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LYME DISEASE BORRELIA BURGDORFERI DNA QUALITATIVE REAL TIME PCR Test

Test Name: LYME DISEASE BORRELIA BURGDORFERI DNA QUALITATIVE REAL TIME PCR Test

Components: Price 3460.0 AED

Sample Condition: 2 mL (1 mL min.) CSF / Synovial Fluid in a sterile screw capped container. Ship refrigerated or frozen. Duly filled Test Send Out Consent Form is mandatory.

Report Delivery: Sample by 7th of the month; Report after 2-3 weeks

Method: Real Time PCR

Test type: Infections

Doctor: Physician

Test Department: OS

Pre Test Information: Duly filled Test Send Out Consent Form is mandatory.

Test Details

The Lyme disease (Borrelia burgdorferi) DNA qualitative real-time PCR test is a diagnostic tool used to detect the presence of Borrelia burgdorferi, the bacterium responsible for causing Lyme disease. This test uses the polymerase chain reaction (PCR) technique to amplify and detect specific DNA sequences of the bacterium.

During the test, a sample is collected from the patient, typically a blood sample, and the DNA is extracted from the sample. The PCR technique is then used to amplify specific regions of the Borrelia burgdorferi DNA, if present in the sample. This amplification process allows for the detection and quantification of the DNA in real-time.

The real-time PCR test is highly sensitive and specific, allowing for the detection of even small amounts of Borrelia burgdorferi DNA in the sample. It can be used to confirm a diagnosis of Lyme disease in patients with symptoms consistent with the disease or to monitor the effectiveness of treatment.

It is important to note that the PCR test detects the presence of Borrelia burgdorferi DNA, not the presence of active infection or the presence of antibodies. Therefore, it is possible for the test to yield a positive result in individuals who have been previously infected with Lyme disease but are no longer actively infected.

Overall, the Lyme disease DNA qualitative real-time PCR test is a valuable tool in the diagnosis and management of Lyme disease, allowing for early detection and appropriate treatment.

Test Name LYME DISEASE BORRELIA BURGDORFERI DNA QUALITATIVE REAL TIME PCR Test
Components
Price 3460.0 AED
Sample Condition 2 mL (1 mL min.) CSF \/ Synovial Fluid in a sterile screw capped container. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory.
Report Delivery Sample by 7th of the month; Report after 2??3 weeks
Method Real Time PCR
Test type Infections
Doctor Physician
Test Department: OS
Pre Test Information Duly filled Test Send Out Consent Formis mandatory.
Test Details

The Lyme disease (Borrelia burgdorferi) DNA qualitative real-time PCR test is a diagnostic tool used to detect the presence of Borrelia burgdorferi, the bacterium responsible for causing Lyme disease. This test uses the polymerase chain reaction (PCR) technique to amplify and detect specific DNA sequences of the bacterium.

During the test, a sample is collected from the patient, typically a blood sample, and the DNA is extracted from the sample. The PCR technique is then used to amplify specific regions of the Borrelia burgdorferi DNA, if present in the sample. This amplification process allows for the detection and quantification of the DNA in real-time.

The real-time PCR test is highly sensitive and specific, allowing for the detection of even small amounts of Borrelia burgdorferi DNA in the sample. It can be used to confirm a diagnosis of Lyme disease in patients with symptoms consistent with the disease or to monitor the effectiveness of treatment.

It is important to note that the PCR test detects the presence of Borrelia burgdorferi DNA, not the presence of active infection or the presence of antibodies. Therefore, it is possible for the test to yield a positive result in individuals who have been previously infected with Lyme disease but are no longer actively infected.

Overall, the Lyme disease DNA qualitative real-time PCR test is a valuable tool in the diagnosis and management of Lyme disease, allowing for early detection and appropriate treatment.